Atlas Trials

Utility of Adjusting Chemotherapy Dose & Dosing Schedule With the SALVage Weekly Dose-dense Regimen in Patients With Poor Prognostic OVARian Cancers Based on the Tumor Unfavorable Primary Chemosensitivity and Incomplete Debulking Surgery

Clinical trial NCT06476184 · RECRUITING

Trial details

NCT number
NCT06476184
Sponsor
ARCAGY/ GINECO GROUP
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
2024-07-30
Primary completion
2027-06-01
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.